Biggest News Aggregation in the World
๐Ÿ“ฐ Adhd News

Page 68 - Adhd News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Adhd. Real-time updates on events, politics, business and more.

'Duality': A tale of a mother and her son

"Duality" is an artistic collaboration between Salma Zakia Bristy and her son, Mashrafi Aveen. Each mother shares a unique story with her child, and Bristy is no exception. A visual artist and mother of two, her younger son Aveen has Autism Spectrum Disorder (ASD) with ADHD personality traits, as diagnosed by doctors when he was 18 months old.
Salma Zakia Bristy Mashrafi Aveen Kala Kendra Shishir Bhattacharjee Tahrin Aman University Of Dhaka

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Diagnosing adult ADHD: What you ought to know

When a child is diagnosed with attention-deficit/hyperactivity disorder (ADHD), many parents begin to look at their own emotions and behaviour with new eyes. Might they also have ADHD, as yet unrecognized? After all, it can run in families. "For a lot of adults, an ADHD diagnosis for their child is the first impetus to be tested themselves," says Dr Matthias Rudolph, a specialist in psychosomatic medicine and psychotherapy. And for good reason, because ADHD is a genetically determined,...
Matthias Rudolph Carolin Zimmermann World Health Organization Adult Adhd R Matthias Rudolph Psychosomatic Medicine
Source: yahoo.com

Former BBC journalist turned academic is suing a university after it passed him over for promotion due to a lack of a doctorate - claiming his insomnia means he is too tired to study for a PhD

Media law lecturer Simon Pipe, 62, who teaches at Coventry University, has applied for a promotion four times between 2017 and 2020, but has been shot down each time for his lack of a PhD.
City Of United Kingdom Justice Moylan Lady Justice Elisabeth Laing Zenobia Zaiwalla Coventry University

ADHD field presents significant opportunity for drug developers

Stimulants, amphetamines, and methylphenidates are currently the first-line treatment for moderate to severe attention-deficit/hyperactivity disorder (ADHD) across the seven major global markets; France, Germany, Italy, Spain, the UK, the US, and Japan.
Lorraine Palmer Globaldata Kols Cingulate Inc Neurocentria Incl Threonate Magnesium Salt Axsome Therapeutics Inc Neurocentria Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science